Azilsartan Kamedoxomil Patent Expiration

Azilsartan Kamedoxomil is Used for lowering blood pressure. It was first introduced by Azurity Pharmaceuticals Inc in its drug Edarbi on Feb 25, 2011. 2 different companies have introduced drugs containing Azilsartan Kamedoxomil.


Azilsartan Kamedoxomil Patents

Given below is the list of patents protecting Azilsartan Kamedoxomil, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Edarbi US9066936 Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent Mar 26, 2028 Azurity
Edarbi US7157584 Benzimidazole derivative and use thereof May 22, 2025 Azurity
Edarbi US7572920 Benzimidazole derivative and use as a II receptor antagonist Jan 07, 2025 Azurity
Edarbi US5958961 Pharmaceutical composition for angiotensin II-mediated diseases Jun 06, 2014

(Expired)

Azurity
Edarbi US5583141 Heterocyclic compounds and their use as angiotensin antagonists Dec 10, 2013

(Expired)

Azurity



Azilsartan Kamedoxomil's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Azilsartan Kamedoxomil Generic API Manufacturers

Several generic applications have been filed for Azilsartan Kamedoxomil.

Given below is the list of companies who have filed for Azilsartan Kamedoxomil generic, along with the locations of their manufacturing plants worldwide.


1. LUPIN LTD

Lupin Ltd has filed for 2 different strengths of generic version for Azilsartan Kamedoxomil. All of these versions come by the name AZILSARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG MEDOXOMIL

tablet Discontinued ORAL N/A Jul 20, 2022
EQ 80MG MEDOXOMIL

tablet Discontinued ORAL N/A Jul 20, 2022


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.